Corvus Pharmaceuticals Chief Business Officer Jeffrey Arcara Acquires 4,500 Common Shares for $50,475.215

• Corvus Pharmaceuticals Chief Business Officer Jeffrey Arcara purchased 4,500 common shares, bringing his direct holdings to 4,500 shares.
• Purchases included 3,000 shares at $11.4602 per share and 497 shares at $11.115.
• The remaining purchases comprised 503 shares at $10.37 per share and 500 shares at $10.7087.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corvus Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001610717-26-000454), on November 13, 2026, and is solely responsible for the information contained therein.